0677.Hk
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.
Business. The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing industry, generating revenue primarily through the retail sale of food and drug products.
The company's capital structure is characterized by a debt-to-equity ratio of 0.38, indicating a relatively conservative leverage position. Its liquidity is assessed as medium, with a current ratio of 1.72, suggesting the company has sufficient short-term assets to cover its short-term liabilities. However, the company's price-to-book ratio of 0.46 and price-to-tangible-book ratio of 0.46 indicate that the market values the company's equity at a discount to its book value.
Profitability metrics show a mixed picture. The company reported a net loss of -14,466,000 HKD, resulting in a negative return on equity of -1.14% and a negative return on assets of -0.69%. These figures are below the typical performance of the industry, which generally expects positive returns on equity and assets. The company's gross profit of 794,496,000 HKD and operating income of 4,699,000 HKD suggest some level of operational efficiency, but the net loss indicates significant non-operational expenses or challenges.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of segment and geographic diversification could expose the company to higher concentration risk, particularly if demand in its primary market fluctuates.
Looking ahead, the company's growth trajectory is uncertain. The available data does not provide specific outlook figures for the current or next fiscal year, but the negative net income and low profitability metrics suggest potential challenges in achieving revenue growth. The company's operating cash flow of 262,124,000 HKD and free cash flow of 78,796,000 HKD indicate some capacity to fund operations and investments, but the negative net income may limit long-term growth prospects.
Risk factors include a medium liquidity risk, as the company's net cash is negative after subtracting total debt. The dilution risk is assessed as low, with no significant dilution potential identified in the basic shares outstanding. The company's capital structure and financial performance suggest that it may need to manage its debt and improve profitability to sustain operations and growth.
Recent events and filings do not provide specific details on new initiatives or strategic changes. The company's financial performance and risk profile suggest that it may need to address operational inefficiencies and improve its financial health to meet its long-term objectives.
- The company has a conservative debt-to-equity ratio of 0.38, indicating a relatively low leverage position.
- The company's profitability is weak, with a negative return on equity of -1.14% and a negative return on assets of -0.69%.
- The company's liquidity is assessed as medium, with a current ratio of 1.72.
- The company's revenue is concentrated in a single business segment, increasing its exposure to market fluctuations.
- The company's net cash is negative after subtracting total debt, indicating potential liquidity challenges.
- The company's growth trajectory is uncertain, with no specific outlook figures provided for the current or next fiscal year.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- 0677.HK Market data — financials · 2026-05-26
Ownership & reference
Leadership
- Laurent LamExecutive Chairman of the Board